Brief: Teva And Natco Announce Launch Of Additional Strengths For The Generic Version Of Revlimid® (Lenalidomide Capsules), In The U.S.

Natco Pharma

09/03/2023 13:15

March 9 (Reuters) - Teva Pharmaceutical Industries Ltd
 TEVA.TA :
    * TEVA AND NATCO ANNOUNCE LAUNCH OF ADDITIONAL STRENGTHS FOR
THE
GENERIC VERSION OF REVLIMID® (LENALIDOMIDE CAPSULES), IN THE
U.S.
    * TEVA - LAUNCH OF ADDITIONAL STRENGTHS FOR GENERIC VERSION
OF
REVLIMID®(1) (LENALIDOMIDE CAPSULES), IN 2.5 MG, AND 20 MG
STRENGTHS, IN UNITED STATES

Source text for Eikon:  ID:nBw1vlW1Da 
Further company coverage:  TEVA.TA 

 ((Reuters.Briefs@thomsonreuters.com;))